FDA recalls heart drugs made by Teva, others over carcinogen impurity

Discussion in 'Market News' started by sniper-academy, Jul 14, 2018.


Draft saved Draft deleted
  1. sniper-academy

    sniper-academy Administrator Staff Member

    Joined:
    Sep 30, 2011
    Messages:
    260,216
    Likes Received:
    5
    The Food and Drug Administration issued a voluntary recall late Friday of high-blood pressure and heart drugs containing the ingredient valsartan because of impurity issues. Affected companies include Teva Pharmaceuticals Industries Ltd. , Solco Healthcare, and Major Pharmaceuticals, the FDA said. The agency said valsartan used in the affected products contained N-nitrosodimethylamine, which is classified as a probable human carcinogen. "We have carefully assessed the valsartan-containing medications sold in the United States, and we've found that the valsartan sold by these specific companies does not meet our safety standards," said Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, in a statement.

    Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

    [​IMG]
    [​IMG] [​IMG] [​IMG] [​IMG]

    Continue reading...
     
Loading...

Share This Page